W
WAVEMAN · COMPANY
ACFN · Acorn Energy, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475
← ALL COMPANIES

ACFN

ACORN ENERGY, INC.
PHARMA & BIOTECH · SERVICES-ENGINEERING SERVICES · CIK 0000880984
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
6
13F, latest reported quarter
REVENUE GROWTH
+4.5%
XBRL, annual
NET MARGIN
21.9%
CONVERSIONS · 180D
1
codes C/M, not in net · $8.4K priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
6 funds added or opened last quarter
below 92% of Pharma & Biotech
REVENUE
+4.5% year over year
more than 53% of Pharma & Biotech
MARGIN
21.9% net margin
more than 90% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
0.4% of shares outstanding short · 1.1 days to cover · settled 2026-07-31
below 80% of Pharma & Biotech
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -32.8%
-32.8%12M
-54%-33%-12%+10%2025-092025-102025-122026-032026-052026-072026-09
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows 6 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for ACORN ENERGY, INC. in the period covered. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER
FILED
SHARES
VALUE
LOEB JAN H
President and CEO
BUY
2023-06-09
20,000.0
$5.6K
Clifford Tracy Simmons
CFO
BUY
2023-06-09
3,487.0
$976
Clifford Tracy Simmons
CFO
BUY
2023-06-02
3,950.0
$1.1K
Clifford Tracy Simmons
CFO
BUY
2023-06-01
563.0
$158
LOEB JAN H
President and CEO
BUY
2023-05-15
45,600.0
$12.8K
15 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 10 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
VANGUARD CAPITAL MANAGEMENT LLC
37,981.0 sh
$646.8K
GEODE CAPITAL MANAGEMENT, LLC
18,168.0 sh
$309.7K
CITADEL ADVISORS LLC
16,321.0 sh
$277.9K
BRIDGEWAY CAPITAL MANAGEMENT, LLC
12,500.0 sh
$212.9K
Mink Brook Asset Management LLC
10,000.0 sh
$170.3K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Ultra-Small Company Fund
$124.1K POSITION · AS OF 2026-03-31
0.1%
Fidelity Extended Market Index Fund
$181.6K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$310.1K POSITION · AS OF 2026-03-31
0.0%
Fidelity Nasdaq Composite Index Fund
$23.7K POSITION · AS OF 2026-02-28
0.0%
Fidelity Series Total Market Index Fund
$47.4K POSITION · AS OF 2026-02-28
0.0%
Fidelity Total Market Index Fund
$56.1K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2024
$334.4K
$334.4K
$229.3K
2023
$321.1K
$321.1K
$228.0K
2022
$326.1K
$326.1K
$225.9K
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · THIS FILER REPORTED NO RETURN FIGURES
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$11.5M$11.0M$8.1M$7.0M
GROSS PROFIT$8.8M$8.0M$6.0M$5.1M
OPERATING INCOME$2.0M$1.9M$74.0K$-629.0K
NET INCOME$2.5M$6.3M$119.0K$-633.0K
EPS (DILUTED)0.992.510.05-0.25
OPERATING CASH FLOW$2.1M$905.0K$72.0K$31.0K
CASH$4.5M$2.3M$1.4M$1.4M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-04 ALL SYSTEMS LIVE FOR MACHINES →